| Literature DB >> 30106964 |
Katharine D Harper1, Courtney Quinn1, Joshua Eccles2, Frederick Ramsey3, Saqib Rehman1.
Abstract
BACKGROUND: Recent literature has demonstrated that emergent administration of antibiotics is perhaps more critical than even emergent debridement. Most recent studies recommend patients receive antibiotics no later than 1 hour after injury to prevent infection. The objective of this study is to evaluate the time to antibiotic administration after patients with open fractures arrive to a trauma center depending on triaging team.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30106964 PMCID: PMC6091925 DOI: 10.1371/journal.pone.0202013
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient demographic data.
| No. of Patients | 117 |
| Age (years) | 35.2 ± 13.9 (1 SD) |
| Female | 29 (24.8%) |
| Male | 88 (75.2%) |
| BMI (kg/m2) | 29.5 ± 7.3 (1 SD) |
| Transportation Time (min.) | 23.8 ± 9.1 (1 SD) |
| EMS | 83 (70.9%) |
| Police | 13 (11.1%) |
| Transfer | 7 (6.0%) |
| Walk-in | 14 (12.0%) |
| Upper Extremity | 36 (30.8%) |
| Lower Extremity | 81 (69.2%) |
| Type I | 53 (45.3%) |
| Type II | 25 (21.4%) |
| Type IIIa | 25 (21.4%) |
| Type IIIb | 10 (8.5%) |
| Type IIIc | 4 (3.4%) |
Summary of patient demographic data including age ranges and average BMI, as well as injury statistics including site of injury and Gustilo classification
Summary of timing to cefazolin administration.
| Time to Cefazolin by Gender | 0.347 | t-test | 0.011 | Wilcoxon | |||||
| Female | 26 | 55 | 63 | 31 | 15–81 | ||||
| Male | 83 | 40 | 71 | 14 | 10–30 | ||||
| Time to Cefazolin by Gustilo Type | 0.491 | ANOVA | 0.532 | Kruskal-Wallis | |||||
| 1 | 50 | 56 | 89 | 18 | 10–58 | ||||
| 2 | 25 | 36 | 38 | 19 | 12–36 | ||||
| 3a | 20 | 31 | 47 | 15 | 9–31 | ||||
| 3b | 10 | 34 | 64 | 13 | 10–22 | ||||
| 3c | 4 | 17 | 16 | 13 | 8–27 | ||||
| Time to Cefazolin by if Antibiotics given in ER | 0.046 | t-test | 0.001 | Wilcoxon | |||||
| Yes | 102 | 34 | 49 | 15 | 10–31 | ||||
| No | 7 | 177 | 151 | 214 | 41–245 | ||||
| Time to Cefazolin by Trauma Team Activation | 0.059 | t-test | <0.0001 | Wilcoxon | |||||
| Yes | 85 | 37 | 71 | 14 | 10–26 | ||||
| No | 24 | 67 | 59 | 53 | 28–89 |
Summary of the timing to cefazolin administration as compared to variables including gender, Gustilo type, if antibiotics were given in the emergency department and if the patient was upgraded to a trauma team activation.
Fig 1Timing of cefazolin for all patients.
Demonstration of the distribution of patients and their associated time to cefazolin administration. Patients are not classified based on open fracture type or triaging group.
Summary of timing to gentamicin administration.
| Time to Gentamicin by Gender | 0.189 | ANOVA | 0.729 | Wilcoxon | |||||
| Female | 16 | 249 | 177 | 208 | 131–354 | ||||
| Male | 31 | 423 | 657 | 167 | 93–477 | ||||
| Time to Gentamicin by Gustilo Type | 0.962 | ANOVA | 0.817 | Kruskal-Wallis | |||||
| 1 | 3 | 271 | 266 | 165 | 74–574 | ||||
| 2 | 13 | 337 | 416 | 188 | 104–346 | ||||
| 3a | 19 | 334 | 629 | 176 | 87–233 | ||||
| 3b | 10 | 480 | 664 | 227 | 116–510 | ||||
| 3c | 2 | 424 | 462 | 424 | 97–750 | ||||
| Time to Gentamicin by if Antibiotics given in ER | 0.285 | t-test | 0.026 | Wilcoxon | |||||
| Yes | 43 | 299 | 414 | 175 | 93–346 | ||||
| No | 4 | 1078 | 1199 | 625 | 393–1764 | ||||
| Time to Gentamicin by Trauma Team Activation | 0.860 | t-test | 0.375 | Wilcoxon | |||||
| Yes | 43 | 370 | 569 | 176 | 93–365 | ||||
| No | 4 | 319 | 188 | 263 | 178–460 |
Summary of the timing to gentamicin administration as compared to variables including gender, Gustilo type, if antibiotics were given in the emergency department and if the patient was upgraded to a trauma team activation.
Fig 2Timing of gentamicin for all patients.
Demonstration of the distribution of all patients and their associated time to gentamicin administration. Patients are not classified based on open fracture type or triaging group.
Time to cefazolin partitioned by trauma team activation and gender.
| Trauma & Male | 68 | 36 | 75 | 13 | 9–23 |
| No Trauma & Male | 15 | 56 | 46 | 41 | 19–76 |
| Trauma & Female | 17 | 39 | 52 | 19 | 10–36 |
| No Trauma & Female | 9 | 85 | 75 | 81 | 36–89 |
| Total | 109 | 43 | 69 | 17 | 10–40 |